About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Foxl2tm2.1Tre
targeted mutation 2.1, Mathias Treier
MGI:4430192
Summary 4 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Foxl2tm2.1Tre/Foxl2tm2.1Tre
Gnrhrtm1.1(cre)Uboe/Gnrhr+
involves: 129S1/Sv * 129X1/SvJ MGI:7286309
cn2
Foxl2tm2.1Tre/Foxl2tm2.1Tre
Gt(ROSA)26Sortm9(cre/ESR1)Arte/?
involves: 129S/Sv * C57BL/6 MGI:4430332
cn3
Foxl2tm2.1Tre/Foxl2tm2.1Tre
Tg(Cga-cre)3Sac/0
involves: C57BL/6 * SJL MGI:4430333
cn4
Foxl2tm2.1Tre/Foxl2tm2.1Tre
Tg(Gdf9-icre)5092Coo/0
involves: C57BL/6 * SJL MGI:4430334


Genotype
MGI:7286309
cn1
Allelic
Composition
Foxl2tm2.1Tre/Foxl2tm2.1Tre
Gnrhrtm1.1(cre)Uboe/Gnrhr+
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Foxl2tm2.1Tre mutation (0 available); any Foxl2 mutation (15 available)
Gnrhrtm1.1(cre)Uboe mutation (0 available); any Gnrhr mutation (20 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
reproductive system
• some males show more severe effects on sperm motility than others, indicating variable asthenospermia
• however, 70% of males show normal sperm vigor and progression
• 30% of males lack motile sperm
• after natural mating, corpora lutea counts are significantly lower than in controls
• female subfertility is at least partly due to a reduction in ovarian follicle development and/or ovulation, not a primary ovarian defect
• 6- to 11-week-old females show a 34% reduction in normalized ovary weights relative to control females
• however, all follicles at all stages are observed
• normalized uterine weights are normal
• all males have tubules exhibiting disorganized spermatogenic stages, retention of spermatids, sloughing of germ cells, and presence of pyknotic cells
• lumina are either decreased in size or absent in many testes
• however, no increase in apoptotic cell number is detected by TUNEL staining
• males show a 43% reduction in Sertoli cell numbers
• 8- to 13-week-old males show significantly lower normalized testes weights than control males
• however, normalized seminal vesicles and epididymal weights are normal
• ovaries of randomly-cycling females show significantly lower Lhr and Ccnd2 mRNA levels than control ovaries
• testes show significantly higher Fshr mRNA levels than control testes
• males display a range of spermatogenic defects, spanning from mild alterations in spermatogenic cell associations to a complete arrest of spermatogenesis
• testicular and cauda epididymal sperm counts are reduced by 61% and 75%, respectively
• some males exhibit a complete arrest of spermatogenesis, as shown by a lack of luminal spermatids
• in some cases, spermatogenesis is arrested at meiosis; few to no haploid round spermatids are observed
• females show a slight delay in vaginal opening relative to controls
• in natural matings, 65-day-old females ovulate significantly fewer cumulus-oocyte complexes (COCs) than controls
• however, juvenile (24- to 28-day-old) females ovulate normal COC numbers after exogenous gonadotropin stimulation (eCG plus hCG)
• some females appear to spend extended periods of time in estrus
• however, no significant differences in the number of cycles per 5 days or % of time spent in each cycle stage are observed
• adult females produce fewer total litters than controls when paired with wild-type males for a period of 6 months
• litter frequency (per 30 days) is significantly reduced in females, but not in males
• average litter size is reduced by 56% in females (J:204036)
• average litter size is reduced by 35% in males (J:204036)
• adult males produce fewer total litters than controls when paired with wild-type females for a period of 6 months
• 4 of 7 males cumulatively produced 23 litters and 87% of all pups, whereas remaining 3 males only sired 4 total litters, indicating variable penetrance in males

homeostasis/metabolism
• serum LH levels are significantly decreased in adult males relative to controls
• however, serum testosterone levels are normal
• serum LH levels are increased 2.5-fold in randomly-cycling females relative to controls
• however, 17beta-estradiol levels are normal in metestrus/diestrus staged females
• adult mice show a significant decrease in FSHB protein and Fshb mRNA expression in their pituitaries
• however, pituitary size and cell density are normal
• serum FSH levels are significantly reduced in both adult males and randomly-cycling females relative to age-matched controls
• FSH deficiency is likely secondary to a selective reduction in pituitary Fshb expression

endocrine/exocrine glands
• after natural mating, corpora lutea counts are significantly lower than in controls
• female subfertility is at least partly due to a reduction in ovarian follicle development and/or ovulation, not a primary ovarian defect
• 6- to 11-week-old females show a 34% reduction in normalized ovary weights relative to control females
• however, all follicles at all stages are observed
• normalized uterine weights are normal
• all males have tubules exhibiting disorganized spermatogenic stages, retention of spermatids, sloughing of germ cells, and presence of pyknotic cells
• lumina are either decreased in size or absent in many testes
• however, no increase in apoptotic cell number is detected by TUNEL staining
• males show a 43% reduction in Sertoli cell numbers
• 8- to 13-week-old males show significantly lower normalized testes weights than control males
• however, normalized seminal vesicles and epididymal weights are normal
• ovaries of randomly-cycling females show significantly lower Lhr and Ccnd2 mRNA levels than control ovaries
• testes show significantly higher Fshr mRNA levels than control testes

cellular
• testicular and cauda epididymal sperm counts are reduced by 61% and 75%, respectively
• some males show more severe effects on sperm motility than others, indicating variable asthenospermia
• however, 70% of males show normal sperm vigor and progression
• 30% of males lack motile sperm

growth/size/body
N
• mice develop normally and have body sizes and weights indistinguishable from controls

craniofacial
N
• mice do not display any craniofacial defects




Genotype
MGI:4430332
cn2
Allelic
Composition
Foxl2tm2.1Tre/Foxl2tm2.1Tre
Gt(ROSA)26Sortm9(cre/ESR1)Arte/?
Genetic
Background
involves: 129S/Sv * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Foxl2tm2.1Tre mutation (0 available); any Foxl2 mutation (15 available)
Gt(ROSA)26Sortm9(cre/ESR1)Arte mutation (2 available); any Gt(ROSA)26Sor mutation (942 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
reproductive system
• almost entire structure is affected by 3 weeks following tamoxifen treatment
• instead of normal granulosa cells, cells with morphological characteristics of Sertoli cells (prominent basal lamina, tripartite nuclei, numerous veil-like cytoplasmic extensions pointing toward lumen) are observed 3 weeks following tamoxifen treatment; Leydig cell markers are also detected in mutant gonads
• one week after start of tamoxifen treatment, many granulosa cells start to transdifferentiate into Sertoli-like cells; unlike normal granulosa cells, these abnormal cells do not undergo apoptosis at end of a follicle life cycle and are still present after 6 months
• 3 weeks following tamoxifen treatment, typical follicular structure of ovary resembles seminiferous tubules of testis
• 8-week-old female mice treated for 5 days with tamoxifen and analysed 3 weeks later exhibit gonadal sex reversal

endocrine/exocrine glands
• almost entire structure is affected by 3 weeks following tamoxifen treatment
• instead of normal granulosa cells, cells with morphological characteristics of Sertoli cells (prominent basal lamina, tripartite nuclei, numerous veil-like cytoplasmic extensions pointing toward lumen) are observed 3 weeks following tamoxifen treatment; Leydig cell markers are also detected in mutant gonads
• one week after start of tamoxifen treatment, many granulosa cells start to transdifferentiate into Sertoli-like cells; unlike normal granulosa cells, these abnormal cells do not undergo apoptosis at end of a follicle life cycle and are still present after 6 months
• 3 weeks following tamoxifen treatment, typical follicular structure of ovary resembles seminiferous tubules of testis




Genotype
MGI:4430333
cn3
Allelic
Composition
Foxl2tm2.1Tre/Foxl2tm2.1Tre
Tg(Cga-cre)3Sac/0
Genetic
Background
involves: C57BL/6 * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Foxl2tm2.1Tre mutation (0 available); any Foxl2 mutation (15 available)
Tg(Cga-cre)3Sac mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
reproductive system
• almost entire structure is affected
• instead of normal granulosa cells, cells with morphological characteristics of Sertoli cells (prominent basal lamina, tripartite nuclei, numerous veil-like cytoplasmic extensions pointing toward lumen) are observed
• typical follicular structure of ovary resembles seminiferous tubules of testis
• size is increased compared to control females
• female mice exhibit gonadal sex reversal

endocrine/exocrine glands
• almost entire structure is affected
• instead of normal granulosa cells, cells with morphological characteristics of Sertoli cells (prominent basal lamina, tripartite nuclei, numerous veil-like cytoplasmic extensions pointing toward lumen) are observed
• typical follicular structure of ovary resembles seminiferous tubules of testis
• size is increased compared to control females




Genotype
MGI:4430334
cn4
Allelic
Composition
Foxl2tm2.1Tre/Foxl2tm2.1Tre
Tg(Gdf9-icre)5092Coo/0
Genetic
Background
involves: C57BL/6 * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Foxl2tm2.1Tre mutation (0 available); any Foxl2 mutation (15 available)
Tg(Gdf9-icre)5092Coo mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
reproductive system
N
• mice have no fertility defects





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/23/2024
MGI 6.23
The Jackson Laboratory